PAR 6.98% 20.0¢ paradigm biopharmaceuticals limited..

PAR CEO explains SAS patient results in interview, page-36

  1. 166 Posts.
    lightbulb Created with Sketch. 35
    I agree , it is probably the biggest hurdle to overcome these big pharma companies that do not want to lose business and have some very influential connections , you only have to look at the last USA election to see what happens when the people really pulling the strings want a particular outcome .
 
watchlist Created with Sketch. Add PAR (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.